This inventor holds 1 USPTO granted patent. Top assignee: National Cancer Center. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: The Innovations of Dohoon Lee
Introduction
Dohoon Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of antibodies.
Latest Patents
One of his notable patents is a monoclonal antibody against cotinine and nicotine. This invention aims to neutralize cotinine, a metabolite of nicotine, which has implications for smoking cessation and public health.
Career Highlights
Dohoon Lee is currently affiliated with the National Cancer Center, where he focuses on innovative research that addresses critical health issues. His work is instrumental in advancing the understanding of nicotine's effects on the body.
Collaborations
He collaborates with esteemed colleagues, including Junho Chung and Jae-Gahb Park, to further enhance the impact of their research in the field.
Conclusion
Dohoon Lee's contributions to the development of monoclonal antibodies represent a significant advancement in biomedical research. His work continues to influence the fight against nicotine addiction and improve public health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
